NCT03558854View on ClinicalTrials.gov

Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 28, 2018

Primary Completion Date

September 2, 2021

Study Completion Date

October 26, 2021

Conditions
Systemic Sclerosis
Interventions
DRUG

Acetylsalicylic acid

Patients will be randomized to take one pill of either acetylsalicylic acid or placebo once daily for 4 weeks

DRUG

Placebo oral capsule

Patients will be randomized to take one pill of either acetylsalicylic acid or placebo once daily for 4 weeks

Trial Locations (1)

Unknown

Systemic Sclerosis Outpatient Clinic, Hospital São Paulo, São Paulo

All Listed Sponsors
lead

Federal University of São Paulo

OTHER

NCT03558854 - Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma Patients | Biotech Hunter | Biotech Hunter